Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Paratek and Glaxo Wellcome to discover and develop new antibiotics

July 30, 1999

Inhibitex's U.S. patent for S. aureus attachment gene allowed

July 29, 1999

FDA approves Relenza for treatment of influenza

July 28, 1999

Magainin's Locilex cream not approvable says FDA

July 27, 1999

FDA requests additional data to support n-docosanol NDA

July 27, 1999

Cerus initiates phase III U.S. trial of platelet pathogen inactivation system

July 27, 1999

Licensing/CRADA opportunity from NIH: eosinophil-derived neutralizing agent

July 26, 1999

Quinolone antibiotic-Mg2+ complexes have superior physicochemical/pharmacokinetic properties

July 23, 1999

Gemini Technologies awarded SBIR grant to study 2-5A antisense compound

July 23, 1999

Ro-64-0796/GS-4104: potential drug interactions and beneficial effects in patients with the flu

July 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....